Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMP/SMX dosing optimization in septic patients on CRRT
ChiCTR2400088397Phase 4Not yet recruiting
- Sponsor
- Hainan People's Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of trimethoprim + sulfamethoxazole in sepsis, sponsored by Hainan People's Hospital. Primary endpoints: Blood concentration and Drug clearance. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR2400088397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088397.